HEADER PROTEIN BINDING/INHIBITOR 22-SEP-15 5DW1 TITLE X-RAY CRYSTAL STRUCTURE OF HUMAN BRD2(BD2) IN COMPLEX WITH RVX297 TO TITLE 2 1.55 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: BD2 (UNP RESIDUES 345-455); COMPND 5 SYNONYM: O27.1.1, REALLY INTERESTING NEW GENE 3 PROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD2, KIAA9001, RING3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PJEXPRESS401 KEYWDS BROMODOMAIN, PROTEIN BINDING-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.WHITE,E.FONTANO,R.K.SUTO REVDAT 3 06-MAR-24 5DW1 1 JRNL REMARK LINK REVDAT 2 20-JUL-16 5DW1 1 JRNL REVDAT 1 22-JUN-16 5DW1 0 JRNL AUTH O.A.KHARENKO,E.M.GESNER,R.G.PATEL,K.NOREK,A.WHITE,E.FONTANO, JRNL AUTH 2 R.K.SUTO,P.R.YOUNG,K.G.MCLURE,H.C.HANSEN JRNL TITL RVX-297- A NOVEL BD2 SELECTIVE INHIBITOR OF BET JRNL TITL 2 BROMODOMAINS. JRNL REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 477 62 2016 JRNL REFN ESSN 1090-2104 JRNL PMID 27282480 JRNL DOI 10.1016/J.BBRC.2016.06.021 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 80774 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.161 REMARK 3 R VALUE (WORKING SET) : 0.159 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4250 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3641 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 126 REMARK 3 SOLVENT ATOMS : 583 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.59000 REMARK 3 B22 (A**2) : 0.28000 REMARK 3 B33 (A**2) : 0.09000 REMARK 3 B12 (A**2) : 0.23000 REMARK 3 B13 (A**2) : 0.13000 REMARK 3 B23 (A**2) : -0.34000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.068 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.074 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.049 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.386 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5DW1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1000213896. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.075 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 85026 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.42600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.03 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.6 M SODIUM MALONATE, PH 7.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 343 REMARK 465 MET A 344 REMARK 465 SER B 343 REMARK 465 MET B 344 REMARK 465 LYS B 345 REMARK 465 SER C 343 REMARK 465 MET C 344 REMARK 465 LYS C 345 REMARK 465 SER D 343 REMARK 465 MET D 344 REMARK 465 LYS D 345 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS B 351 CG CD CE NZ REMARK 470 GLU C 348 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 402 O HOH A 601 2.12 REMARK 500 NZ LYS D 400 O HOH D 601 2.14 REMARK 500 OE1 GLU D 413 O HOH D 602 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 447 CD GLU A 447 OE1 0.072 REMARK 500 PHE A 448 CG PHE A 448 CD1 0.104 REMARK 500 ASP B 444 CB ASP B 444 CG 0.129 REMARK 500 GLU B 447 CD GLU B 447 OE1 0.072 REMARK 500 GLU C 447 CD GLU C 447 OE1 0.090 REMARK 500 GLU D 447 CD GLU D 447 OE1 0.066 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 373 CB - CG - CD1 ANGL. DEV. = 4.3 DEGREES REMARK 500 ASP A 444 CB - CG - OD2 ANGL. DEV. = -6.5 DEGREES REMARK 500 ARG A 449 NE - CZ - NH1 ANGL. DEV. = -3.6 DEGREES REMARK 500 ARG A 449 NE - CZ - NH2 ANGL. DEV. = 6.0 DEGREES REMARK 500 TYR B 373 CB - CG - CD1 ANGL. DEV. = 4.3 DEGREES REMARK 500 TYR B 373 CZ - CE2 - CD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP B 385 CB - CG - OD1 ANGL. DEV. = 6.3 DEGREES REMARK 500 ARG B 409 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 ARG B 409 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 PHE B 448 CB - CG - CD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 TYR C 373 CB - CG - CD1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG C 406 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 ASP C 417 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ARG C 419 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 MET C 438 CG - SD - CE ANGL. DEV. = -10.4 DEGREES REMARK 500 ASP C 444 CB - CG - OD1 ANGL. DEV. = 9.5 DEGREES REMARK 500 ASP C 444 CB - CG - OD2 ANGL. DEV. = -11.3 DEGREES REMARK 500 PHE C 448 CB - CG - CD2 ANGL. DEV. = -4.4 DEGREES REMARK 500 TYR D 373 CB - CG - CD1 ANGL. DEV. = 4.5 DEGREES REMARK 500 ARG D 406 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG D 419 NE - CZ - NH2 ANGL. DEV. = -4.6 DEGREES REMARK 500 ASP D 444 CB - CG - OD1 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP D 444 CB - CG - OD2 ANGL. DEV. = -7.8 DEGREES REMARK 500 PHE D 448 CB - CG - CD2 ANGL. DEV. = -4.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 752 DISTANCE = 6.83 ANGSTROMS REMARK 525 HOH C 754 DISTANCE = 6.03 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA D 502 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 661 O REMARK 620 2 HOH A 671 O 73.3 REMARK 620 3 HOH A 699 O 77.8 71.6 REMARK 620 4 HOH B 646 O 113.6 167.1 98.6 REMARK 620 5 GLY D 382 O 85.5 85.1 154.4 105.9 REMARK 620 6 HOH D 683 O 160.4 92.1 110.5 83.5 80.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA C 502 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP C 377 OD1 REMARK 620 2 SER C 379 OG 80.5 REMARK 620 3 HOH C 679 O 93.9 83.2 REMARK 620 4 HOH C 712 O 173.8 93.8 87.8 REMARK 620 5 HOH C 719 O 101.9 175.5 92.8 84.0 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5GD A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5GD B 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5GD C 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA C 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5GD D 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA D 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5DW2 RELATED DB: PDB DBREF 5DW1 A 345 455 UNP P25440 BRD2_HUMAN 345 455 DBREF 5DW1 B 345 455 UNP P25440 BRD2_HUMAN 345 455 DBREF 5DW1 C 345 455 UNP P25440 BRD2_HUMAN 345 455 DBREF 5DW1 D 345 455 UNP P25440 BRD2_HUMAN 345 455 SEQADV 5DW1 SER A 343 UNP P25440 EXPRESSION TAG SEQADV 5DW1 MET A 344 UNP P25440 EXPRESSION TAG SEQADV 5DW1 SER B 343 UNP P25440 EXPRESSION TAG SEQADV 5DW1 MET B 344 UNP P25440 EXPRESSION TAG SEQADV 5DW1 SER C 343 UNP P25440 EXPRESSION TAG SEQADV 5DW1 MET C 344 UNP P25440 EXPRESSION TAG SEQADV 5DW1 SER D 343 UNP P25440 EXPRESSION TAG SEQADV 5DW1 MET D 344 UNP P25440 EXPRESSION TAG SEQRES 1 A 113 SER MET LYS LEU SER GLU GLN LEU LYS HIS CYS ASN GLY SEQRES 2 A 113 ILE LEU LYS GLU LEU LEU SER LYS LYS HIS ALA ALA TYR SEQRES 3 A 113 ALA TRP PRO PHE TYR LYS PRO VAL ASP ALA SER ALA LEU SEQRES 4 A 113 GLY LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO MET SEQRES 5 A 113 ASP LEU SER THR VAL LYS ARG LYS MET GLU ASN ARG ASP SEQRES 6 A 113 TYR ARG ASP ALA GLN GLU PHE ALA ALA ASP VAL ARG LEU SEQRES 7 A 113 MET PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS SEQRES 8 A 113 ASP VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE SEQRES 9 A 113 GLU PHE ARG TYR ALA LYS MET PRO ASP SEQRES 1 B 113 SER MET LYS LEU SER GLU GLN LEU LYS HIS CYS ASN GLY SEQRES 2 B 113 ILE LEU LYS GLU LEU LEU SER LYS LYS HIS ALA ALA TYR SEQRES 3 B 113 ALA TRP PRO PHE TYR LYS PRO VAL ASP ALA SER ALA LEU SEQRES 4 B 113 GLY LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO MET SEQRES 5 B 113 ASP LEU SER THR VAL LYS ARG LYS MET GLU ASN ARG ASP SEQRES 6 B 113 TYR ARG ASP ALA GLN GLU PHE ALA ALA ASP VAL ARG LEU SEQRES 7 B 113 MET PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS SEQRES 8 B 113 ASP VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE SEQRES 9 B 113 GLU PHE ARG TYR ALA LYS MET PRO ASP SEQRES 1 C 113 SER MET LYS LEU SER GLU GLN LEU LYS HIS CYS ASN GLY SEQRES 2 C 113 ILE LEU LYS GLU LEU LEU SER LYS LYS HIS ALA ALA TYR SEQRES 3 C 113 ALA TRP PRO PHE TYR LYS PRO VAL ASP ALA SER ALA LEU SEQRES 4 C 113 GLY LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO MET SEQRES 5 C 113 ASP LEU SER THR VAL LYS ARG LYS MET GLU ASN ARG ASP SEQRES 6 C 113 TYR ARG ASP ALA GLN GLU PHE ALA ALA ASP VAL ARG LEU SEQRES 7 C 113 MET PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS SEQRES 8 C 113 ASP VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE SEQRES 9 C 113 GLU PHE ARG TYR ALA LYS MET PRO ASP SEQRES 1 D 113 SER MET LYS LEU SER GLU GLN LEU LYS HIS CYS ASN GLY SEQRES 2 D 113 ILE LEU LYS GLU LEU LEU SER LYS LYS HIS ALA ALA TYR SEQRES 3 D 113 ALA TRP PRO PHE TYR LYS PRO VAL ASP ALA SER ALA LEU SEQRES 4 D 113 GLY LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO MET SEQRES 5 D 113 ASP LEU SER THR VAL LYS ARG LYS MET GLU ASN ARG ASP SEQRES 6 D 113 TYR ARG ASP ALA GLN GLU PHE ALA ALA ASP VAL ARG LEU SEQRES 7 D 113 MET PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS SEQRES 8 D 113 ASP VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE SEQRES 9 D 113 GLU PHE ARG TYR ALA LYS MET PRO ASP HET 5GD A 500 31 HET 5GD B 500 31 HET 5GD C 501 31 HET NA C 502 1 HET 5GD D 501 31 HET NA D 502 1 HETNAM 5GD 2-{3,5-DIMETHYL-4-[2-(PYRROLIDIN-1-YL)ETHOXY]PHENYL}-5, HETNAM 2 5GD 7-DIMETHOXYQUINAZOLIN-4(3H)-ONE HETNAM NA SODIUM ION FORMUL 5 5GD 4(C24 H29 N3 O4) FORMUL 8 NA 2(NA 1+) FORMUL 11 HOH *583(H2 O) HELIX 1 AA1 SER A 347 LEU A 361 1 15 HELIX 2 AA2 SER A 362 LYS A 364 5 3 HELIX 3 AA3 HIS A 365 TRP A 370 1 6 HELIX 4 AA4 PRO A 371 TYR A 373 5 3 HELIX 5 AA5 ASP A 377 GLY A 382 1 6 HELIX 6 AA6 ASP A 385 ILE A 390 1 6 HELIX 7 AA7 ASP A 395 ASN A 405 1 11 HELIX 8 AA8 ASP A 410 ASN A 429 1 20 HELIX 9 AA9 HIS A 433 LYS A 452 1 20 HELIX 10 AB1 SER B 347 LEU B 361 1 15 HELIX 11 AB2 SER B 362 LYS B 364 5 3 HELIX 12 AB3 HIS B 365 TRP B 370 1 6 HELIX 13 AB4 PRO B 371 TYR B 373 5 3 HELIX 14 AB5 ASP B 377 GLY B 382 1 6 HELIX 15 AB6 ASP B 385 ILE B 390 1 6 HELIX 16 AB7 ASP B 395 ASN B 405 1 11 HELIX 17 AB8 ASP B 410 ASN B 429 1 20 HELIX 18 AB9 HIS B 433 LYS B 452 1 20 HELIX 19 AC1 SER C 347 LEU C 361 1 15 HELIX 20 AC2 SER C 362 LYS C 364 5 3 HELIX 21 AC3 HIS C 365 TRP C 370 1 6 HELIX 22 AC4 PRO C 371 TYR C 373 5 3 HELIX 23 AC5 ASP C 385 ILE C 390 1 6 HELIX 24 AC6 ASP C 395 ASN C 405 1 11 HELIX 25 AC7 ASP C 410 ASN C 429 1 20 HELIX 26 AC8 HIS C 433 LYS C 452 1 20 HELIX 27 AC9 SER D 347 LEU D 361 1 15 HELIX 28 AD1 SER D 362 LYS D 364 5 3 HELIX 29 AD2 HIS D 365 TRP D 370 1 6 HELIX 30 AD3 PRO D 371 TYR D 373 5 3 HELIX 31 AD4 ASP D 377 GLY D 382 1 6 HELIX 32 AD5 ASP D 385 ILE D 390 1 6 HELIX 33 AD6 ASP D 395 ASN D 405 1 11 HELIX 34 AD7 ASP D 410 ASN D 429 1 20 HELIX 35 AD8 HIS D 433 LYS D 452 1 20 LINK O HOH A 661 NA NA D 502 1554 1555 2.42 LINK O HOH A 671 NA NA D 502 1554 1555 3.05 LINK O HOH A 699 NA NA D 502 1554 1555 2.56 LINK O HOH B 646 NA NA D 502 1545 1555 2.59 LINK OD1 ASP C 377 NA NA C 502 1555 1555 2.40 LINK OG SER C 379 NA NA C 502 1555 1555 2.49 LINK NA NA C 502 O HOH C 679 1555 1555 2.27 LINK NA NA C 502 O HOH C 712 1555 1555 2.28 LINK NA NA C 502 O HOH C 719 1555 1555 2.38 LINK O GLY D 382 NA NA D 502 1555 1555 2.38 LINK NA NA D 502 O HOH D 683 1555 1555 2.31 SITE 1 AC1 10 TRP A 370 PRO A 371 PHE A 372 VAL A 376 SITE 2 AC1 10 LEU A 381 LEU A 383 ASN A 429 HIS A 433 SITE 3 AC1 10 HOH A 626 HOH D 636 SITE 1 AC2 13 PRO B 371 PHE B 372 VAL B 376 LEU B 381 SITE 2 AC2 13 LEU B 383 ASN B 429 HIS B 433 VAL B 435 SITE 3 AC2 13 HOH B 616 HOH B 630 HOH C 629 HOH C 643 SITE 4 AC2 13 HOH C 689 SITE 1 AC3 14 TRP B 370 ALA B 380 TRP C 370 PRO C 371 SITE 2 AC3 14 PHE C 372 VAL C 376 LEU C 381 ASN C 429 SITE 3 AC3 14 HIS C 433 HOH C 625 HOH C 651 HOH C 672 SITE 4 AC3 14 HOH C 690 HIS D 384 SITE 1 AC4 5 ASP C 377 SER C 379 HOH C 679 HOH C 712 SITE 2 AC4 5 HOH C 719 SITE 1 AC5 14 TRP A 370 ALA A 380 SER B 379 HIS B 384 SITE 2 AC5 14 PRO D 371 PHE D 372 VAL D 376 LEU D 381 SITE 3 AC5 14 LEU D 383 ASN D 429 HIS D 433 HOH D 630 SITE 4 AC5 14 HOH D 678 HOH D 701 SITE 1 AC6 6 HOH A 661 HOH A 671 HOH A 699 HOH B 646 SITE 2 AC6 6 GLY D 382 HOH D 683 CRYST1 56.289 57.318 62.033 62.09 72.08 66.08 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017765 -0.007880 -0.002867 0.00000 SCALE2 0.000000 0.019086 -0.008200 0.00000 SCALE3 0.000000 0.000000 0.018440 0.00000